Results of enfortumab vedotin (EV) therapy for metastatic urothelial carcinoma (mUC)

Kotoe Matsuda

講演情報

Oral case study/Oral presentation

Oral Presentation 4

2023年10月28日(土) 10:30 〜 11:20 Room 2: Subaru EAST (Hotel Nikko Tsukuba Annex Bldg.1F)

Chair: Toshiyuki Kamoto (University of Miyazaki), Cheryn Song (University of Ulsan College of Medicine, Asan Medical Center)

[OP4-05] Results of enfortumab vedotin (EV) therapy for metastatic urothelial carcinoma (mUC)

*Kotoe Matsuda¹, Takashi Kawahara¹, Masanobu Shiga¹, Yoshiyuki Nagumo¹, Atsushi Ikeda¹, Tomokazu Kimura¹, Akio Hoshi¹, Hiromitsu Negoro¹, Hiroyuki Nishiyam¹ (1. Department of Urology, University of Tsukuba Hospital, Ibaraki, Japan)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。